Journals / Retina-Vitreus / 2018 / Cilt: 27 - Sayı: 4

Use of Vitreon Tamponate in Inferior Rhegmatogeneus Retinal Detachment: Surgical Results and Complications

Yırtıklı Alt Yarı Retina Dekolmanında Vitreon Tamponat Kullanımı: Cerrahi Sonuçlar ve Komplikasyonlar

Pages
351–355
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Vitreon should not be considered primary as an intravitreal tamponade in the case of for inferior rhegmatogenous retinal de- tachment due to various complications in the postoperative period and the high recurrence rates.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: To evaluate the postoperative anatomical and functional success status, postoperative complications and their results of vitreore- tinal surgery (VRC) with the preference of vitreon use as a vitreoretinal (VR) tamponade for inferior rhegmatogenous retinal detachment (RRD).
📊
Key Findings & Data:Methods: Forty-three eyes of 43 patients were retrospectively evaluated.
💡
Conclusion & Impact:Conclusion: Vitreon should not be considered primary as an intravitreal tamponade in the case of for inferior rhegmatogenous retinal de- tachment due to various complications in the postoperative period and the high recurrence rates.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: To evaluate the postoperative anatomical and functional success status, postoperative complications and their results of vitreore- tinal surgery (VRC) with the preference of vitreon use as a vitreoretinal (VR) tamponade for inferior rhegmatogenous retinal detachment (RRD). Methods: Forty-three eyes of 43 patients were retrospectively evaluated. Patients’ etiology of retinal detachment, preoperative ocular diseases, best corrected visual acuity (BCVA), intraocular pressure (IOP) values, biomicroscopic features, detailed fundus examination fi ndings, postoperative complications, anatomical and functional success results were evaluated. Results: Twenty six of the 43 cases were male (62,8%) and 17 were female (37,2%). The mean age of the cases was 50.8±18.8. Ten (23.3%) patients had no predisposing factor for RRD, whereas the most common cause was pseudophakia (13 patients - 30.2%). In the postoperative period, visual acuity (VA) was increased in 20 patients and the initial VA was preserved in 13 patients. In 10 patients, visual acuity was worse than preoperative VA. After removal of the vitreon, the recurrence rate was %39.5. Postoperative anatomical success rate was 60,5%, and functional success rate was 76,7%. The most common postoperative complication was secondary cataract (23,3%). Conclusion: Vitreon should not be considered primary as an intravitreal tamponade in the case of for inferior rhegmatogenous retinal de- tachment due to various complications in the postoperative period and the high recurrence rates.

Özet

Amaç: Alt yarı yırtıklı retina dekolmanı (YRD) nedeniyle vitreoretinal cerrahi (VRC) uygulanan ve tamponat olarak vitreon tercih edilen olguların postoperatif anatomik ve fonksiyonel başarı durumları, postoperatif dönemde görülen komplikasyonları ve bunların sonuçlarını incelemek. Gereç ve Yöntem: Kırk üç hastanın 43 gözü retrospektif olarak değerlendirildi. Hastaların retina dekolmanı etyolojisi, ameliyat öncesi oküler hastalıklar, düzeltilmiş en iyi görme keskinliği, göz içi basıncı (GİB) değerleri, biyomikroskopik özellikleri, detaylı fundus muaye- nesi bulguları, postoperatif dönemde görülen komplikasyonlar, anatomik ve fonksiyonel başarı durumları değerlendirildi. Bulgular: Çalışmaya alınan 43 olgunun 26’sı erkek (% 62,8), 17’si kadın (% 37,2) olup olguların ortalama yaşı 50,8±18,8 idi. On (%23,3) hastada YRD için herhangi bir predispozan faktör bulunmazken, tespit edilebilen en sık sebep psödofaki idi (13 hasta-%30,2). Postope- ratif dönemde 20 hastada görme artışı sağlanırken, 13 hastada ilk görme keskinliği durumu korundu. 10 hastada ise preoperatif görme keskinliğinden daha kötü bir görme düzeyi elde edildi. Vitreon çıkarılması sonrası % 39,5 oranında nüks görüldü. Postoperatif anatomik başarı oranı % 60,5 iken, fonksiyonel başarı oranı % 76,7 idi. Postoperatif dönemde görülen en sık görülen komplikasyon sekonder kata- rakttı (%23,3). Sonuç: Vitreon, postoperatif dönemde çeşitli komplikasyonlara yol açması ve nüks oranlarının fazlalığından dolayı, alt yarı yırtıklı dekol- man olgularında intravitreal tamponad olarak kullanımı öncelikli olarak düşünülmemelidir.

🔖

Cite This Article

KIZILTOPRAK, H., TEKİN, K., TEKE, M. Y. (2018). Use of Vitreon Tamponate in Inferior Rhegmatogeneus Retinal Detachment: Surgical Results and Complications. Retina-Vitreus, Cilt: 27 - Sayı: 4, 351–355. https://ajindex.com/articles/304845

References (14)

  1. Cibis PA, Becker B, Okun F, et al. The use of liquid silicone in retinal detachment surgery. Arch Ophthalmol 1962; 68: 590-9
  2. Nabih M, Peyman GA, Clark LC Jr, et al. Experimental evaluation of perfl uorophenanthrene as a high specifi c gravity vitreous subs- tituite: a preliminary report. Ophthalmic Surg 1989; 20: 286-93
  3. Tanji TM, Peyman GA, Mehta NJ, et al. Vitreon Study Group. Perfl uoroperhydrophenantbrene Vitreon as a shortterm vitreous substitute after complex vitreoretinal surgery. Ophthalmic Surg 1993; 24: 681-5
  4. Charles S, Randolph JC, Sigler EJ. Pars plana vitrectomy reopera- tion without removing silicone oil. Retina 2012; 32: 1664-5
  5. Sharma A, Grigoropoulos V, Williamson TH. Management of pri- mary rhegmatogenous retinal detachment with inferior breaks. Br J Ophthalmol 2004; 88: 1372-5
  6. Sigler EJ, Randolph JC, Calzada JI, et al. Pars plana vitrectomy with medium-term postoperative perfl uoro-N-octane for recurrent inferior retinal detachment complicated by advanced proliferative vitreoretinopathy. Retina 2013; 33: 791-7
  7. Auriol S, Pagot-Mathis V, Mahieu L, et al. Effi cacy and safety of heavy silicone oil Densiron-68 in the treatment of complicated retinal detachment with large inferior retinectomy. Graefes Arch Clin Exp Ophthalmol 2008; 246: 1383-9
  8. Hoerauf H, Kobuch K, Dresp J et al. Combined use of partially fl uorinated alkanes, perfl uorocarbon liquids and silicone oil: an ex- perimental study. Graefes Arch Clin Exp Ophthalmol 2001; 239: 373-81
  9. Stolba U, Krepler K, Pfl ug R et al. Experimental vitreous and aqueous replacement with perfl uorophenanthrene. Clinical, histo- logic, and electrophysiologic results. Retina 1997; 17: 146-53
  10. Ratiglia R, Berti E, Galimberti D et al. Experimental vitreous rep- lacement with perfl uorophenanthrene. Eur J Ophthalmol 1997; 7: 59-63
  11. Soheilian M, Peyman GA, Wafapoor H et al. Surgical management of traumatic retinal detachment with perfl uorocarbon liquid. The Vitreon Study Group. Int Ophthalmol 1996; 20: 241-9
  12. Cekiç O, Batman C, Totan Y et al. Management of traumatic reti- nal detachment with vitreon in children. Int Ophthalmol, 1999; 23: 145-8.
  13. Kertes PJ, Wafapoor H, Peyman GA, et al. The management of giant retinal tears using perfl uoroperhydrophenanthrene. A multi- center case series. Vitreon Collaborative Study Group. Ophthal- mology 1997; 104: 1159-65
  14. Millsap CM, Peyman GA, Mehta NJ, et al. Perfl uoroperhydrop- henanthrene (Vitreon) in the management of giant retinal tears: results of a collaborative study